Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-21 to 2023-04-11
Current total value of award: $2007.78
Description: 4560374300!ZOLADEX 3.6 MG IMPLANT SYRNS